The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Quest Diagnostics

  • DGX
  • NYSE
  • Other Services
  • Latest 59.04
  • Currency US$
  • Change -0.31
  • Percent Change -0.522 %
  • Volume 880,536
  • Thu Jul 10, 2014 04:03 PM EDT NYSE data delayed 15 minutes.
  • Open 59.00
  • Previous Close 59.35
  • High 59.27
  • Low 58.84
  • Bidx2 57.91
  • Askx2 60.03
  • 52-week High11/11 64.10
  • 52-week Low02/07 50.46
  • Beta 0.613
  • Market Cap 8,520.06M
  • EPS 3.95
  • P/E 14.947
  • Forward P/E 13.60
  • PEG 1.43
  • Annual Dividend 1.32
  • Yield 2.236
Globe Investor - GIT Upsells
It's never been a better time to get Globe Unlimited
Try Globe Unlimited, featuring new Globe Investor Tools,
for a special trial rate. Only 99¢ for your first month.


Are you a Globe Investor Gold subscriber?
You qualify for complimentary access to Globe Unlimited.
Visit: globeandmail.com/globeplusunlimited
Try it today

News

Financials & Calendars

Income Statement

  • Sales $7,104,800,000
  • Earnings $817,600,000
  • Return on Equity 20.46%

Cash Flow

  • Cash Flow --
  • Cash $144,000,000
  • Current Ratio 1.25

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $9,550,000,000
  • Liabilities $5,530,000,000
  • Liabilities-to-Equity Ratio 1.38

Price Ratios

  • Price to Sales 1.20
  • Price to Book 2.12
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Apr 24 $0.89 Jul 24 $1.06
Surprises Apr 24 -5.62% n/a n/a
Dividends Jul 7 $0.33 n/a n/a
Splits n/a -- n/a n/a

12 months ended Jul 10, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.

Related Securities
Symbol Type Latest % Chg

Officers

  • Daniel C. Stanzione Chairman of the Board
  • Stephen H. Rusckowski President and Chief Executive
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

3 GIRALDA FARMS
MADISON, NJ
07940

Phone: (973)-520-2700
Fax: (201)-4624169

investor@questdiagnostics.com
www.questdiagnostics.com

Ideas & Discussion

Live Discussion of DGX on StockTwits